Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Rating)‘s stock had its “outperform” rating reiterated by equities researchers at Wedbush in a report issued on Tuesday, RTT News reports. They presently have a $51.00 price objective on the stock, down from their prior price objective of $71.00. Wedbush’s price objective would suggest a potential upside of 154.11% from […]
Analysts expect Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) to announce ($1.21) earnings per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Zentalis Pharmaceuticals’ earnings, with estimates ranging from ($1.36) to ($1.08). Zentalis Pharmaceuticals reported earnings of ($1.24) per share during the same quarter last year, which would indicate […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating)’s stock price reached a new 52-week low during trading on Monday after Stifel Nicolaus lowered their price target on the stock from $94.00 to $74.00. The stock traded as low as $31.61 and last traded at $31.63, with a volume of 24090 shares changing hands. The stock had […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating)’s stock price was down 15.8% during mid-day trading on Friday . The company traded as low as $39.07 and last traded at $40.88. Approximately 45,146 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 465,891 shares. The stock had previously closed […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) has earned a consensus recommendation of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year target […]